TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹101 Cr | ₹-142 Cr | ₹-300 Cr | ₹-422 Cr | ₹-433 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹101 Cr |
Mar2023 | ₹-142 Cr |
Mar2022 | ₹-300 Cr |
Mar2021 | ₹-422 Cr |
Mar2020 | ₹-433 Cr |
How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹101 Cr | Positive | |
Mar2023 | ₹-142 Cr | Negative | |
Mar2022 | ₹-300 Cr | Negative | |
Mar2021 | ₹-422 Cr | Negative | |
Mar2020 | ₹-433 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹108,927.6 Cr | 1.4% | 1.3% | 17% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
MANKIND PHARMA | ₹98,130.4 Cr | 0.2% | -2.4% | 12.5% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 1.4% |
1.3% |
17% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses